About file location

As the EGA is co-managed by the EMBL-EBI and CRG, files could be located in the UK and/or Spain, as indicated by their respective flags.

Alternatively, files could be located in one of the international Federated EGA nodes, as indicated next to the node's flag.
Need Help?

smRNA-Seq assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, as part of the International Human Epigenome Consortium.

smRNA-Seq assays for reference epigenomes generated by Centre for Epigenome Mapping Technologies at Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Canada as part of the International Human Epigenome Consortium.

Request Access

DUO:0000012
version: 2021-02-23

research specific restrictions

This data use modifier indicates that use is limited to studies of a certain research type.

DUO:0000025
version: 2021-02-23

time limit on use

This data use modifier indicates that use is approved for a specific number of months.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

BC Cancer, part of the Provincial Health Services Authority - Data Access Policy

Access to this data is controlled. There are a number of steps that a researcher must take to obtain access to this data, including execution of a Data Access Agreement between the institutions. The process is overseen by the Technology Development Office; please contact our general email address TDOadmin@phsa.ca. Please only click the "request data" button on the EGA website after a Data Access Agreement is fully executed.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000552 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
i
EGAF00000701542 bam 951.0 MB Report
EGAF00000701543 bam 401.0 MB Report
EGAF00000701544 bam 712.1 MB Report
EGAF00000701545 bam 575.3 MB Report
EGAF00000701546 bam 102.1 MB Report
EGAF00000701547 bam 134.3 MB Report
EGAF00000701548 bam 127.8 MB Report
EGAF00000701549 bam 177.4 MB Report
EGAF00000701550 bam 154.4 MB Report
EGAF00000701551 bam 146.0 MB Report
EGAF00000701552 bam 776.7 MB Report
EGAF00000701553 bam 350.0 MB Report
EGAF00000701554 bam 447.1 MB Report
EGAF00000701555 bam 384.3 MB Report
EGAF00000701556 bam 502.9 MB Report
EGAF00000701557 bam 338.4 MB Report
EGAF00000701558 bam 113.8 MB Report
EGAF00000701559 bam 744.6 MB Report
EGAF00000701560 bam 814.4 MB Report
EGAF00000701561 bam 355.1 MB Report
EGAF00000701562 bam 284.7 MB Report
EGAF00000867664 bam 546.4 MB Report
EGAF00000867668 bam 580.3 MB Report
EGAF00000867670 bam 791.9 MB Report
EGAF00000867672 bam 546.9 MB Report
EGAF00000867673 bam 392.5 MB Report
EGAF00000867675 bam 375.0 MB Report
EGAF00000867677 bam 563.4 MB Report
28 Files (12.4 GB)